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Introduction
Since the publication of the Kidney Disease Outcomes Quality Initiative clinical practice guidelines on the classification of chronic kidney disease (CKD) in 2002 [1] , studies based on this classification system have shown high prevalence estimates of CKD in the general population [2] [3] [4] . Therefore, CKD has received increased attention as a leading public health concern in recent years. Recently, there has been an ongoing discussion on whether the current CKD criteria and classification are appropriate, especially among population with estimated glomerular filtration rate (eGFR) >30 mL/min/1.73m 2 and among the elderly [5, 6] . However, longitudinal studies of the mortality and renal outcomes among those populations are limited, especially among developing countries.
Therefore, we initiated this prospective study among a community-based Chinese population >40 years of age (with an average age of 60 years) and with an eGFR >30 mL/min/1.73m 2 , in order to investigate the relationship between indicators of kidney damage and mortality as well as renal function decline.
Materials and methods

Study population
In 2004, 2310 residents aged !40 years from an urban district of Beijing were evaluated for CKD and associated factors [7] . Four years later, survival status and indicators of kidney damage were reevaluated. Due to the city planning of Beijing, part of the participants moved out of the area. Therefore, we were able to follow 67.7% (n ¼ 1563) of them. Except for age (59.9 AE 9.5 versus 61.1 AE 10.4, P ¼ 0.007), responders were comparable to nonresponders in sex distribution (percentage of male 49.5 versus 49.4%, P ¼ 0.97), prevalence of hypertension (46.9% versus 47.4%, P ¼ 0.86) and prevalence of diabetes (27.7 versus 28.7%, P ¼ 0.66).
Evaluation of renal function and albuminuria at baseline
Details have been described elsewhere [7] . In brief, blood was collected after an overnight fast of at least 10 h. Serum creatinine was measured by Jaffe kinetic method on a Hitachi 7170 autoanalyzer (Hitachi, Tokyo, Japan). eGFR was calculated using the equation developed from data based on Chinese patients with CKD [8] .
Albumin and creatinine were measured on a spot urine sample. Albuminuria was measured by immunoturbidimetric methods (Audit Diagnostics, Cork, Ireland). Urinary creatinine was measured by the same means as serum creatinine. A urinary albumin-to-creatinine ratio (ACR, milligram per gram) was then calculated. Albuminuria was defined by ACR !30 mg/ g in females and ACR !20 mg/g in males.
Evaluation of covariates at baseline
Information on sociodemographic status, personal health history and lifestyle behavior was obtained through a questionnaire. Each participant underwent weight and height measurements, using a calibrated scale. The body mass index (BMI) was calculated as weight (in kilograms) divided by height squared (in square meters). Blood pressure (BP) was measured according to the guidelines presented in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood pressure [9] . Three readings were taken at 5-min intervals. Means of the three readings were calculated, unless the difference between the readings was >10 mmHg, in which case the mean of the two closest measurements was used. Hypertension was defined as systolic BP !140 mmHg or diastolic BP !90 mmHg or use of antihypertensive medications. Diabetes was diagnosed by means of a standard 75 g oral glucose tolerance test except in those with a known history of diabetes. Diabetes was defined as fasting plasma glucose !7.0 mmol/L or 2-h plasma glucose !11.1 mmol/L or medical record-confirmed history. Plasma uric acid, triglycerides and high-density lipoprotein (HDL) cholesterol were measured by Hitachi 7170 autoanalyzer (Hitachi).
Outcomes
All deaths were confirmed by medical record review. Causes of death, classified according to International Classification of Diseases-9, were acquired from the medical records.
The eGFR and albuminuria were reevaluated using the same strategy as in 2008. Intraassay coefficients of variation for creatinine and urinary albumin were 3.7 and 3.9%, respectively.
Renal function decline was defined as presence of at least one of two criteria: i) baseline eGFR <90 mL/min/1.73m 2 and eGFR decreased !20% during 4-years of follow-up; ii) eGFR decreased !20% during 4-years of follow-up and eGFR <60 mL/min/1.73m 2 in 2008. The association between baseline albuminuria, baseline eGFR and allcause mortality was analyzed using Logistic regression models. We analyzed eGFR as both binary variable (<60 mL/min/1.73m 2 versus !60 mL/ min/1.73m
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2 ) and continuous variable (per 5 mL/min/1.73m 2 decrease) in separate models. Age-and sex-adjusted odds ratios (ORs) with 95% confidence interval (CI) were reported. We then used forward selection method to build a parsimonious model to adjust for other confounders. Covariates under consideration included age (per 5-year increase), sex (female versus male), BMI (per 5 kg/m 2 increase), history of cardiovascular disease (CVD, yes/no), current smoking (yes/no), systolic BP (per 10 mmHg increase), diabetes (yes/no), plasma uric acid (per 59 lmol/L increase), plasma triglycerides and plasma HDL cholesterol (per 1 mmol/L increase). We forced age and gender into the model. For covariates that did not enter the model, we then added them to the model individually. If the OR of albuminuria or eGFR changed >20%, we then kept it in the final model. The final model included age, gender, current smoking, systolic BP and history of diabetes.
The association between albuminuria, eGFR and renal function decline was analyzed using logistic regression models. We analyzed eGFR as both binary variable (<60 mL/min/1.73m 2 versus !60 mL/min/1.73m
2 ) and continuous variable (per 5 mL/min/1.73m 2 decrease) in separate models. Other covariates in the models included age (per 5-year increase), sex (female versus male), BMI (per 5 kg/m 2 increase), history of CVD (yes/no), current smoking (yes/no), systolic BP (per 10 mmHg increase), diabetes (yes/no), plasma uric acid (per 59 lmol/L increase), plasma triglycerides and plasma HDL cholesterol (per 1 mmol/L increase). We also investigated whether there is an interaction between eGFR (<60 mL/min/1.73m 2 or !60 mL/min/1.73 m 2 ) and albuminuria. Appropriate interaction term was generated to test whether interactions were statistically significant. Furthermore, we limited analysis to those with baseline eGFR !60 mL/min/1.73m 2 as a secondary analysis.
All P-values are two tailed. Statistical tests were performed using SPSS statistical package, version 10.0 (SPSS, Inc., Chicago, IL).
Results
At baseline, the mean age of 1563 participants was 59.5 AE 9.4 years, and 48.5% were males ( 2 ). Comparisons of baseline characteristics between those with and without renal function decline are shown in Table 3 . After adjusting for potential confounders, presence of albuminuria was significantly associated with renal function decline, with an OR of 1.79 (95% CI 1.02-3.15, Table 4 ). The multivariable OR for eGFR (<60 versus !60 mL/min/1.73 m 2 ) was 0.79 (95% CI 0.42-1.48). We also analyzed eGFR as continuous variable (per 5 mL/min/1.73m 2 decreases) and got a multivariable OR of 1.12 (95% CI 1.06-1.19).
We observed an interaction between albuminuria and eGFR (P-value for interaction <0.001). Compared to those with an eGFR !60 and without albuminuria (n ¼ 1377), the risk of renal function decline was not significantly increased among those with eGFR <60 and without albuminuria (n ¼ 76), with a multivariable OR of 0.60 (95% CI 0.29-1.26). The ORs for those with eGFR !60 and with albuminuria (n ¼ 96) and those with both eGFR <60 and albuminuria (n ¼ 13) was 1.46 (95% CI 0.78-2.74) and 3.29 (1.00-10.78), respectively.
Besides albuminuria, plasma uric acid is independently associated with renal function decline, with a multivariable OR of 1.25 (per 59 lmol/L increase, 95% CI 1.10-1.43). We did not observe interaction between sex and plasma uric acid level (P-value for interaction ¼ 0.80). In the secondary analysis limited to those with baseline eGFR !60 mL/min/1.73m 2 (n ¼ 1420), the multivariable OR of plasma uric acid was 1.31 (per 59 lmol/L increase, 95% CI 1.14-1.50). Furthermore, age is also independently associated with renal function decline (OR ¼ 1.35/5 years increase, 95% CI 1.22-1.50).
Discussion
In this prospective study among a community-based Chinese population with an eGFR !30 mL/min/1.73m 2 , albuminuria is a stronger independent predictor for both all-cause mortality and renal function decline compared to eGFR. The risk of renal function decline is highest among those with both albuminuria and eGFR <60 mL/min/ 1.73m 2 . Plasma uric acid is also independently associated with future risk of renal function decline.
CKD is an independent risk factor for CVD and all-cause mortality [10, 11] . Since two major indicators of kidney damage--albuminuria and reduced eGFR--do not largely overlap [12] , investigating the effects of them separately may be helpful to stratify the patients. Several studies suggest that albuminuria predicts cardiovascular outcomes and all-cause mortality independently of eGFR. In a study among 4098 participants with previous myocardial infarction [13] , those with proteinuria (defined as !11 by dipstick) and without reduced renal function (defined as eGFR <60 mL/min/1.73m
2 ) were at higher risk for all-cause mortality compared to those without proteinuria and with reduced renal function [multivariable adjusted hazard ratio (HR) 1.61 (95% CI 1.17-2.20) versus 1.20 (95% CI 0.91-1.58)]. Similarly, a recent study among diabetic patients [14] suggested that the risk of cardiovascular mortality was higher among patients with albuminuria and with an eGFR !60 mL/min/1.73m 2 compared to patients with eGFR 30-59 mL/min/1.73m 2 and without albuminuria. Results from the Framingham Offspring Cohort [15] indicated that those with microalbuminuria and without reduced eGFR (defined as <59 mL/min/1.73m 2 in women or <64 mL/min/1.73m 2 in men) were at increased risk of CVD [age-and sex-adjusted HR ¼ 1.8 (95% CI 1.2-2.5)], while the age-and sex-adjusted HR for CVD among those without albuminuria and with reduced eGFR was 0.9 (95% CI 0.6-1.5). But a similar pattern was not observed in the analysis of total mortality in the Framingham Offspring Cohort [15] . Our study indicated that among this community-based Chinese population with an eGFR !30 mL/min/1.73m 2 , albuminuria was predictive of all-cause mortality, and this effect is independent of smoking, systolic BP, diabetes and eGFR.
Previous studies suggested that increased urinary albumin excretion also may indicate a worse renal prognosis, while some studies did not consider the effect of baseline renal function [16, 17] . Since the prevalence of albuminuria increases with deterioration of renal function [12] , the possibility of positive confounding by eGFR should be considered. In a recent study from United States [18] , it was found that after adjusting for other risk factors including baseline creatinine, even trace proteinuria on urine dipstick was associated with 1.4-fold increased risk for end-stage renal disease (ESRD). Results from the Multiple Risk Factor Intervention Trial also suggested that the HR for ESRD among those with 11 proteinuria (by urine dipstick) and with eGFR 60-75 mL/min/1.73m 2 was 2.80 (95% CI 1.18-6.61), which was comparable to the HR among those with negative/trace proteinuria and with eGFR <60 mL/min/ 1.73m 2 (2.36, 95% CI 1.38-4.01). Our study confirmed that albuminuria was independently associated with risk of renal function decline. Furthermore, the observed interaction between albuminuria and eGFR supports the notion of incorporation albuminuria to all levels of reduced eGFR by Hallan et al. [19] , in order to optimally predict renal function deterioration. In our analysis, besides albuminuria, plasma uric acid was also predictive of renal function decline. Previously, Iseki et al. [20] reported that hyperuricemia (!357 lmol/L) was an independent predictor of ESRD in women; results in men did not achieve statistical significance. We did not observe interaction between uric acid level and sex in our analysis. Results from the Cardiovascular Health Study (CHS) [21] indicated that uric acid levels were strongly associated with prevalent CKD; in longitudinal analysis, no significant association was found between uric acid levels and incident CKD. In a recent study of pooling data from the Atherosclerosis Risks in Communities and the CHS [22] , a modest independent association was found between uric acid level and incident kidney disease (OR ¼ 1.07, 95% CI 1.01-1.14, per 59 lmol/L increase). We observed a stronger association between uric acid level and renal function decline in this Chinese population (OR ¼ 1.25, 95% CI 1.10-1.43, per 59 lmol/L increase). And this association was independent of metabolic disorders, baseline renal function and albuminuria. The relationship remained robust when participants with a baseline eGFR <60 mL/min/1.73m 2 were excluded. Uric acid may be associated with renal function decline through multiple mechanisms: (i) hyperuricemia may cause direct kidney toxicity [23] ; (ii) hyperuricemia may induce or exacerbate hypertension [24, 25] , which is a risk factor for renal function decline; (iii) hyperuricemia may be a marker of the severity of other risk factors, especially metabolic disorders [23] . Furthermore, a randomized trial in 54 patients suggested that allopurinol treatment was related to slower progression of CKD [26] . However, we did not have information of allopurinol use in our study. Besides, a previous study suggests that smoking is associated with CKD [27] . In our analysis, the adjusted OR of current smoking was 0.86 (95% CI 0.55-1.33), which might be due to limited power.
In our results, the median change of eGFR over 4 years was À7.0 mL/min/1.73m 2 (IQR 2.5 to À17.3 mL/min/ 1.73m
2 ), which is comparable to reports from other regions [28] . Higher protein intake was considered to be related with accelerated renal disease progression [29] , while updated data did not support the notion. In China, data from 1983 to 1984 suggested that intake of animal protein was very low in a rural area, only~10% of the US diet [30] . Although the protein intake has increased with the economic development and changes of lifestyle in the last 20 years, the total protein and animal protein intake in China was still lower compared with Western countries [31] . The effect of different dietary patterns on renal disease progression deserves further investigation.
In our study, a 'baseline eGFR <90 mL/min/1.73m 2 ' was included in the definition of renal function decline for the following reasons: First, more than one-fourth of the participants were diabetic, and part of them might have had glomerular hyperfiltration at baseline. It may not be proper to define them as 'renal function decline' solely based on decrease of eGFR. Second, although the modified Modification of Diet in Renal Disease (MDRD) equation based on Chinese patients performed better among those with an eGFR !60 mL/min/1.73 m 2 compared to the MDRD equation [8] , the disagreement between eGFR and reference GFR was still highest among those with an eGFR >90 mL/min/1.73m 2 . Finally, regression to the mean is likely to happen among those with high eGFR results at baseline.
Our study has limitations that deserve mention. First, we only have two measurements of eGFR and albuminuria. Although there may be variations in laboratory measurements, this type of misclassification would tend to bias our study toward not finding an association; therefore, it is possible that we underestimated the true association. Second, as mentioned before, we could only follow 67.7% of participants in our cohort at the second visit; therefore, the possibility of selection bias existed. However, the baseline characteristics were comparable between responders and nonresponders. Third, the number of outcomes during a relatively short period of follow-up limited our power to detect statistically significant findings and to perform further stratified analysis. Finally, since our study was observational, the possibility of residual confounding by some unmeasured covariate exists.
In conclusion, our prospective analysis suggests that albuminuria is a stronger independent predictor for both mortality and renal function decline compared to eGFR among a Chinese population with normal or mildly impaired renal function. The effect of albuminuria on renal function decline is modified by eGFR. Therefore, the discussion about classification of CKD should also focus on albuminuria, especially among those with an eGFR !30 mL/min/1.73m 2 . Furthermore, we find that plasma uric acid level and age are strong independent predictors of renal function decline in this Chinese population and therefore may be used for identifying patients at higher risk of CKD progression. Further experimental studies and intervention studies are needed to clarify whether uric acid directly contributes to kidney injury or is just a marker of kidney risk.
